IBDEI0ZU ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16167,1,3,0)
 ;;=3^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,16167,1,4,0)
 ;;=4^E23.0
 ;;^UTILITY(U,$J,358.3,16167,2)
 ;;=^60685
 ;;^UTILITY(U,$J,358.3,16168,0)
 ;;=E27.1^^61^768^34
 ;;^UTILITY(U,$J,358.3,16168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16168,1,3,0)
 ;;=3^Primary Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,16168,1,4,0)
 ;;=4^E27.1
 ;;^UTILITY(U,$J,358.3,16168,2)
 ;;=^5002740
 ;;^UTILITY(U,$J,358.3,16169,0)
 ;;=E27.2^^61^768^1
 ;;^UTILITY(U,$J,358.3,16169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16169,1,3,0)
 ;;=3^Addisonian Crisis
 ;;^UTILITY(U,$J,358.3,16169,1,4,0)
 ;;=4^E27.2
 ;;^UTILITY(U,$J,358.3,16169,2)
 ;;=^263725
 ;;^UTILITY(U,$J,358.3,16170,0)
 ;;=E27.3^^61^768^4
 ;;^UTILITY(U,$J,358.3,16170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16170,1,3,0)
 ;;=3^Drug-induced Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,16170,1,4,0)
 ;;=4^E27.3
 ;;^UTILITY(U,$J,358.3,16170,2)
 ;;=^5002741
 ;;^UTILITY(U,$J,358.3,16171,0)
 ;;=E29.1^^61^768^35
 ;;^UTILITY(U,$J,358.3,16171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16171,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,16171,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,16171,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,16172,0)
 ;;=E55.9^^61^768^42
 ;;^UTILITY(U,$J,358.3,16172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16172,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,16172,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,16172,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,16173,0)
 ;;=E66.01^^61^768^20
 ;;^UTILITY(U,$J,358.3,16173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16173,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,16173,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,16173,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,16174,0)
 ;;=E66.8^^61^768^24
 ;;^UTILITY(U,$J,358.3,16174,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16174,1,3,0)
 ;;=3^Obesity NEC
 ;;^UTILITY(U,$J,358.3,16174,1,4,0)
 ;;=4^E66.8
 ;;^UTILITY(U,$J,358.3,16174,2)
 ;;=^5002831
 ;;^UTILITY(U,$J,358.3,16175,0)
 ;;=E66.9^^61^768^25
 ;;^UTILITY(U,$J,358.3,16175,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16175,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,16175,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,16175,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,16176,0)
 ;;=E74.39^^61^768^16
 ;;^UTILITY(U,$J,358.3,16176,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16176,1,3,0)
 ;;=3^Intestinal Carbohydrate Absorption Disorder NEC
 ;;^UTILITY(U,$J,358.3,16176,1,4,0)
 ;;=4^E74.39
 ;;^UTILITY(U,$J,358.3,16176,2)
 ;;=^5002928
 ;;^UTILITY(U,$J,358.3,16177,0)
 ;;=E83.30^^61^768^28
 ;;^UTILITY(U,$J,358.3,16177,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16177,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,16177,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,16177,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,16178,0)
 ;;=E83.51^^61^768^9
 ;;^UTILITY(U,$J,358.3,16178,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16178,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,16178,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,16178,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,16179,0)
 ;;=E83.52^^61^768^7
 ;;^UTILITY(U,$J,358.3,16179,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16179,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,16179,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,16179,2)
 ;;=^59932
